| Suehun Ho, | |
|
12680 Perry Hwy Ste 275, Wexford, PA 15090-8887 | |
| (412) 692-4400 | |
| Not Available |
| Full Name | Suehun Ho |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 23 Years |
| Location | 12680 Perry Hwy Ste 275, Wexford, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417050923 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 248558 (New York) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | MD454978 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Passavant | Pittsburgh, PA | Hospital |
| Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Pittsburgh Physicians | 8729990239 | 3721 |
News Archive
Researchers from the Mitochondrial Medicine Frontier Program at Children's Hospital of Philadelphia (CHOP) have demonstrated how one combination of therapies may be beneficial for patients with mitochondrial respiratory chain disorders.
Progenics Pharmaceuticals, Inc. today announced the initiation of a phase 2 clinical trial of subcutaneous methylnaltrexone in Japan by its collaborator, Ono Pharmaceutical Co., Ltd. The drug, designated ONO-3849 in Japan, is being evaluated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness such as cancer.
By a decisive margin of 74-21 percent, Americans support former First Lady Nancy Reagan's call for the Bush White House to lift restrictions on stem cell research in order to look for possible treatments for the Alzheimer's disease
A new report involving mice suggests that a relationship exists between maternal metabolic or psychological stress and the development of obesity, type 2 diabetes, and metabolic syndrome in her offspring. What's more, the report shows that if the stress cannot be reduced or eliminated, manipulating the neuropeptide Y (NPY) system in visceral fat may prevent maternal stress-induced obesity from occurring in the next generation.
Exposure to radioactive iodines, mainly iodine 131 (I-131), in childhood is associated with an increased risk of thyroid cancer. Importantly, both iodine deficiency and supplementation appear to modify this risk, according to a new study in the May 18 issue of the Journal of the National Cancer Institute.
› Verified 4 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
Researchers from the Mitochondrial Medicine Frontier Program at Children's Hospital of Philadelphia (CHOP) have demonstrated how one combination of therapies may be beneficial for patients with mitochondrial respiratory chain disorders.
Progenics Pharmaceuticals, Inc. today announced the initiation of a phase 2 clinical trial of subcutaneous methylnaltrexone in Japan by its collaborator, Ono Pharmaceutical Co., Ltd. The drug, designated ONO-3849 in Japan, is being evaluated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness such as cancer.
By a decisive margin of 74-21 percent, Americans support former First Lady Nancy Reagan's call for the Bush White House to lift restrictions on stem cell research in order to look for possible treatments for the Alzheimer's disease
A new report involving mice suggests that a relationship exists between maternal metabolic or psychological stress and the development of obesity, type 2 diabetes, and metabolic syndrome in her offspring. What's more, the report shows that if the stress cannot be reduced or eliminated, manipulating the neuropeptide Y (NPY) system in visceral fat may prevent maternal stress-induced obesity from occurring in the next generation.
Exposure to radioactive iodines, mainly iodine 131 (I-131), in childhood is associated with an increased risk of thyroid cancer. Importantly, both iodine deficiency and supplementation appear to modify this risk, according to a new study in the May 18 issue of the Journal of the National Cancer Institute.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Suehun Ho, 3471 5th Ave Ste 910, Pittsburgh, PA 15213-3221 Ph: () - | Suehun Ho, 12680 Perry Hwy Ste 275, Wexford, PA 15090-8887 Ph: (412) 692-4400 |
News Archive
Researchers from the Mitochondrial Medicine Frontier Program at Children's Hospital of Philadelphia (CHOP) have demonstrated how one combination of therapies may be beneficial for patients with mitochondrial respiratory chain disorders.
Progenics Pharmaceuticals, Inc. today announced the initiation of a phase 2 clinical trial of subcutaneous methylnaltrexone in Japan by its collaborator, Ono Pharmaceutical Co., Ltd. The drug, designated ONO-3849 in Japan, is being evaluated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness such as cancer.
By a decisive margin of 74-21 percent, Americans support former First Lady Nancy Reagan's call for the Bush White House to lift restrictions on stem cell research in order to look for possible treatments for the Alzheimer's disease
A new report involving mice suggests that a relationship exists between maternal metabolic or psychological stress and the development of obesity, type 2 diabetes, and metabolic syndrome in her offspring. What's more, the report shows that if the stress cannot be reduced or eliminated, manipulating the neuropeptide Y (NPY) system in visceral fat may prevent maternal stress-induced obesity from occurring in the next generation.
Exposure to radioactive iodines, mainly iodine 131 (I-131), in childhood is associated with an increased risk of thyroid cancer. Importantly, both iodine deficiency and supplementation appear to modify this risk, according to a new study in the May 18 issue of the Journal of the National Cancer Institute.
› Verified 4 days ago
Mark M. Mitros, M. D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 7000 Stonewood Dr Ste 151, Wexford, PA 15090 Phone: 724-933-0300 Fax: 724-933-0456 | |
Mark Decotiis, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 7500 Brooktree Rd, Wexford, PA 15090 Phone: 412-367-0600 | |
Dr. Ellen Haidet Mustovic, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 101 N Meadows Dr Ste 112, Wexford, PA 15090 Phone: 724-772-5410 Fax: 724-772-5413 | |
Daniel M Malkamaki, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 7000 Stonewood Dr Ste 151, Wexford, PA 15090 Phone: 724-933-0300 | |
Dr. David Meyer Goldstein, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2500 Brooktree Road, Suite 300, Wexford, PA 15090 Phone: 724-934-7780 Fax: 724-934-7779 | |
Dr. Thomas Joseph Burnett, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 12590 Perry Hwy Ste 700, Wexford, PA 15090 Phone: 724-382-7272 Fax: 724-302-5272 |